Dravet Syndrome Seizures Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Dravet Syndrome Seizures Medications, Costs & Savings
Pharmacist insight
Anti-seizure medications require careful monitoring of blood levels to ensure therapeutic effectiveness. I advise patients never to switch between brand and generic without consulting their pharmacist, as even small differences in absorption can affect seizure control. Medication adherence is the single most important factor.
Angela C. Beverly, PharmD
About Dravet Syndrome Seizures
Dravet Syndrome is a rare, severe form of epilepsy beginning in infancy, characterized by frequent and prolonged seizures that are often difficult to control. Managing this condition requires ongoing medication, which can be costly. TheDrugClub helps families afford these vital prescriptions, offering significant savings to ease the financial burden.
Understanding Dravet Syndrome Seizures
Dravet Syndrome is a rare and severe form of epilepsy that typically begins during the first year of life. It is characterized by frequent, prolonged seizures, often triggered by fever or changes in body temperature. These seizures can be various types, including generalized tonic-clonic (grand mal), myoclonic, and atypical absence seizures. Children with Dravet Syndrome often experience developmental delays, cognitive impairment, and other associated conditions like ataxia (problems with coordination) and sleep disturbances.
The condition is primarily caused by a genetic mutation, most commonly in the *SCN1A* gene, which plays a crucial role in brain cell function. Diagnosis usually involves clinical evaluation, EEG monitoring, and genetic testing. Managing Dravet Syndrome is challenging due to the severity and frequency of seizures, which can be resistant to many conventional anti-epileptic drugs (AEDs).
Treatment Approaches and Medications
Treating Dravet Syndrome often requires a multifaceted approach involving a combination of medications and other therapies. Common antiepileptic drugs specifically approved or frequently used for Dravet Syndrome include:
- Stiripentol (Diacomit): Often used in conjunction with clobazam and valproate.
- Fenfluramine (Fintepla): An oral solution that has shown effectiveness in reducing seizure frequency.
- Cannabidiol (Epidiolex): A plant-derived cannabinoid that has been approved for certain severe epilepsies, including Dravet Syndrome.
- Clobazam (Onfi): A benzodiazepine often used as an add-on therapy.
- Valproate (Depakote): A broad-spectrum AED.
- Topiramate (Topamax): Another AED that can be used.
In addition to medication, non-pharmacological treatments such as the ketogenic diet and vagus nerve stimulation (VNS) may be considered to help manage seizures. Regular monitoring and adjustments to treatment plans are essential, as the effectiveness of medications can vary over time
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.